Chair Letter to Shareholders
http://www.clinuvel.com/wp-content/uploads/2020/03/Chair-Letter-to-Shareholders-1.pdf
http://www.clinuvel.com/wp-content/uploads/2020/03/CLINUVEL-Newsletter-Communiqu%C3%A9-II-2020.pdf
News: CUV UPDATE 1-U.S. FDA approves Clinuvel Pharma's rare genetic disorder treatment, page-100
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.90 |
Change
-0.200(1.42%) |
Mkt cap ! $695.8M | |||
| Open | High | Low | Value | Volume |
| $14.08 | $14.12 | $13.86 | $1.006M | 72.13K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 210 | $13.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.94 | 576 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| CUV (ASX) Chart |